Description

• Effective and well-tolerated once-daily antihypertensive agent, with a tolerability profile similar to placebo.’
• Reduces circulating levels of biochemical markers that are associated with angiotensin Il-mediated endothelial dysfunction and CV risk.”
• Safe and effective alternative for heart failure patient intolerant of ACEinhibitors.”
• Does not adversely affect glucose and lipid metabolism and even improves it.
• Effective at reducing mortality and cardiovascular morbidity in patients who developed heart failure and/or LVSD after surviving an MI